CRC Trials | Aplastic Anemia & MDS International Foundation Return to top.

CRC Trials

Clinical research is at the heart of all medical advances, identifying new ways to prevent, detect or treat disease. If you have a bone marrow failure disease, you may want to consider taking part in a clinical trial, also called a research study.

A Phase II Study of SGI-110 in Philadelphia-Negative Myeloproliferative Neoplasms

Status(es): Active, not recruiting
Study Date(s): Tuesday, March 15, 2016 to Saturday, June 1, 2019
Disease(s): myeloproliferative neoplasms (MPN)
Age Group: 18 years and older
Open label single-arm, single-institution study to evaluate the efficacy and safety of SGI-110 in Philadelphia chromosome negative (Ph-) Myeloproliferative Neoplasms (MPN) (excluding PV, ET and primary/secondary myelofibrosis).  The study will enroll approximately 50 patients at the Weill Cornell Medical College.

A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients with Myelodysplastic Syndrome (MDS)

Status(es): Recruiting
Study Date(s): Friday, May 5, 2017 to Friday, May 1, 2020
Disease(s): myelodysplastic syndromes (MDS)
Age Group: 18 years and older
The goal of this clinical research study is to learn if azacitidine in combination with pembrolizumab can help to control myelodysplastic syndrome (MDS).
Share with